GMED Operating Cash Flow Growth
36.05%TTM
Period ending:
GMED TTM Cash from Operations YoY %%
190.31%-59.59%
2012-12-312026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
GMED operating cash flow growth history
Year-over-year operating cash flow growth rate. The available trailing twelve months (ttm) series contains 55 observations from Dec 31, 2012 to Jun 30, 2026.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 36.0496% | |
| 20.5964% | |
| 44.7161% | |
| 72.3483% | |
| 155.596% | |
| 166.1265% | |
| 113.8153% | |
| 104.6218% | |
| 41.3348% | |
| 29.6551% | |
| 36.4385% | |
| 6.3194% | |
| -21.2057% | |
| -27.3134% | |
| -35.4018% | |
| -31.9263% | |
| -8.2372% | |
| 16.9601% | |
| 38.9757% | |
| 62.045% | |
| 45.9478% | |
| 25.7076% | |
| 15.5941% | |
| 6.7678% | |
| 11.1839% | |
| 3.8647% | |
| -5.3225% | |
| -11.105% | |
| -4.705% | |
| 6.4212% | |
| 13.8578% | |
| 9.3611% | |
| -4.3756% | |
| -6.9961% | |
| -7.1894% | |
| 1.534% | |
| 13.842% | |
| 19.6446% | |
| 40.9456% | |
| 105.5536% | |
| 78.1634% | |
| 68.2236% | |
| 54.0406% | |
| -27.3586% | |
| -20.7575% | |
| -18.9769% | |
| -15.2978% | |
| 36.9062% | |
| 56.4656% | |
| 45.1504% | |
| 22.154% | |
| 0.6799% | |
| -14.7951% | |
| -6.1996% | |
| 0.1427% |
Compare operating cash flow growth
All GMED financial metrics · GMED stock overview · How to interpret financial metrics
